Trials / Unknown
UnknownNCT00547950
A Multiple-Centered, Prospective Cohort Study: the Second Prevention Trial for Ischemic Stroke With Deng Zhan Sheng Mai Capsule（SPIRIT-DZSM-2）
A Model Study on the Comprehensive Treating Protocol of Secondary Prevention and Effect Evaluation of Ischemic Stroke With Traditional Chinese Medicine
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12,000 (estimated)
- Sponsor
- Guangzhou University of Traditional Chinese Medicine · Academic / Other
- Sex
- All
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
In order to observe the influence of the Dengzhan Shengmai Capsule on the endpoint of patients with ischemic stroke, we hold the multi-centered prospective cohort study. From November 2007 to December 2009, 12000 subjects are included in 200 clinical research centers all over China. The subjects naturally formed two cohorts based on taking Dengzhan Shengmai capsule or not. The basic therapy included antiplatelet aggregation , stroke health education, management of blood pressure, blood lipid and blood glucose, etc. Then all of the subjects are visited on the 360th day after inclusion. The recurrence of stroke, cardiovascular events, and peripheral arterial events are observed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | :Deng Zhan Sheng Mai Capsule | capsule，0.18g，2＃，po，Bid\*1year. |
Timeline
- Start date
- 2007-11-01
- Completion
- 2009-10-01
- First posted
- 2007-10-23
- Last updated
- 2007-10-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00547950. Inclusion in this directory is not an endorsement.